Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.
School of Veterinary Medicine, Metropolitan University of Santos, Santos, Brazil.
J Antimicrob Chemother. 2021 Aug 12;76(9):2225-2229. doi: 10.1093/jac/dkab169.
The COVID-19 pandemic has increased relationships and interactions between human and companion animals, supported by widespread social distancing and isolation measures. Additionally, the COVID-19 pandemic has led to an exponential growth in antibiotic and biocide use worldwide, possibly inducing further pressure, contributing to the selection of antibiotic-resistant bacteria, including WHO critical priority pathogens. While data from global surveillance studies reveal a linear trend of increasing carbapenem resistance among Gram-negative pathogens from companion animals, the acquisition of carbapenemase-producing Enterobacterales through direct contact with colonized hosts and contaminated veterinary hospital environments has been documented. This article highlights the rapid spread of WHO critical priority carbapenemase-producing pathogens in companion animals, which is a One Health challenge for a post-pandemic world.
新冠疫情大流行期间,由于广泛采取社交距离和隔离措施,人与伴侣动物之间的关系和互动增加了。此外,新冠疫情大流行导致全球范围内抗生素和杀生物剂的使用呈指数级增长,这可能进一步增加压力,导致包括世界卫生组织(WHO)重点关注病原体在内的抗生素耐药菌的选择。虽然来自全球监测研究的数据显示,从伴侣动物分离出的革兰氏阴性病原体的碳青霉烯类耐药性呈线性趋势上升,但通过与定植宿主的直接接触和受污染的兽医医院环境获得产碳青霉烯酶的肠杆菌科细菌已有记录。本文强调了世界卫生组织重点关注的产碳青霉烯酶病原体在伴侣动物中的快速传播,这是大流行后对“同一健康”的挑战。